scispace - formally typeset
Journal ArticleDOI

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

Reads0
Chats0
TLDR
The present study represents that the combination of HFD-fed and low-dose STZ-treated rat serves as an alternative animal model for type 2 diabetes simulating the human syndrome that is also suitable for testing anti-diabetic agents for the treatment of type 1 diabetes.
About
This article is published in Pharmacological Research.The article was published on 2005-10-01. It has received 1573 citations till now. The article focuses on the topics: Insulin resistance & Glucose tolerance test.

read more

Citations
More filters
Journal ArticleDOI

Antidiabetic effects of water-soluble Korean pine nut protein on type 2 diabetic mice

TL;DR: Korean pine nut protein can regulate fasting blood glucose, improve insulin resistance, correct the glucose metabolism disorder in diabetic mice, and have a positive regulatory role.
Journal ArticleDOI

The nutraceutical potential of Lepidium sativum L. seed flavonoid-rich extract in managing metabolic syndrome components.

TL;DR: The dried LS extract showed an incredible set of effective flavonoids, which revealed hypoglycemic, hypolipidemic, anti-inflammatory, cytoprotective, and antidiabetic activities, which constitute a remarkable product to consider in pharmaceutical industry targeting diabetes and heart diseases.
Journal ArticleDOI

Diphenyleneiodonium Mitigates Bupivacaine-Induced Sciatic Nerve Damage in a Diabetic Neuropathy Rat Model by Attenuating Oxidative Stress.

TL;DR: Subcutaneous injection of DPI appears to protect against the functional and neurohistological damage of bupivacaine-blocked sciatic nerves in a high-fat diet/streptozotocin–induced DN model.
Journal ArticleDOI

Duodenal–Jejunal Bypass Improves Glucose Homeostasis in Association with Decreased Proinflammatory Response and Activation of JNK in the Liver and Adipose Tissue in a T2DM Rat Model

TL;DR: DJB achieved a rapid and sustainable glycemic control independently of weight loss and indicated that the improved proinflammatory state and decreased JNK activity after DJB may contribute to the improved glucose homeostasis.
Journal ArticleDOI

Fluorophore-Dapagliflozin Dyad for Detecting Diabetic Liver/Kidney Damages via Fluorescent Imaging and Treating Diabetes via Inhibiting SGLT2.

TL;DR: In this paper, a fluorophore-dapagliflozin dyad (DX-B-DA) was developed as a theranostic system that can be triggered by intrahepatic/intrarenal reactive oxygen species (ROS) to concomitantly release a near-infrared (NIR) fluorescent dye (DX) and a SGLT2 inhibitor dapaglialozin (DA).
References
More filters
Journal ArticleDOI

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

TL;DR: How advances in the understanding of nuclear receptor function, particularly the docking of cofactors in a ligand-dependent fashion, should lead to improved drugs that utilize the PPAR-gamma system for the treatment of insulin resistance is discussed.
Journal ArticleDOI

Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

TL;DR: Clinical studies in patients with type II diabetes, as well as other syndromes characterized by insulin resistance, have demonstrated that thiazolidinediones may represent a safe and effective new treatment.
Journal ArticleDOI

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

TL;DR: Fat-fed/STZ rats provide a novel animal model for type 2 diabetes, simulates the human syndrome, and is suitable for the testing of antidiabetic compounds.
Related Papers (5)